We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener

Session

Monday
May 15
16:30 - 17:30
Business Suite 1-2
Lung 2
Cécile Le Péchoux, France
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will not be recorded.
3506
Poster Discussion
Clinical
Postoperative IMRT Radiotherapy in resected NSCLC patients: a multicentre retrospective analysis
Valerio Nardone, Italy
PD-0961
Second PFS after post-PACIFIC relapse in the Blue Sky observational study on stage 3 NSCLC.
Jessica Saddi, Italy
PD-0962
Lung re-irradiation with SBRT: outcomes and predictive factors of response in the recurrent setting
Ilaria Angelicone, Italy
PD-0963
SBRT of lung and liver oligometastases from breast cancer:a prospective non-randomized phase 2 trial
Beatrice Marini, Italy
PD-0964
Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors
Rupesh Kotecha, USA
PD-0965
Patterns of recurrence, treatment, and outcome of lymph node recurrence after SBRT for lung cancer
Hyunju Shin, Korea Republic of
PD-0966
Validation of the Graded Prognostic Assessment for Patients with Lung Cancer and Brain Metastases
Soon Woo Hong, Korea Republic of
PD-0967
Treatment of COVID-19 pneumonia with low-dose radiotherapy in frail patients
Barbara Antonia Malave Chacon, Spain
PD-0968
FDG PET/CT follow up imaging of durvalumab maintenance in inoperable stage III NSCLC patients
Adrien Holzgreve, Germany
PD-0969
Biodistribution Data of ImmunoPET: A Phase 0/1 Study Characterising PD-L1 with 89Zr- Durvalumab
Michael MacManus, Australia
PD-0970
Radiation dose response of bone marrow during chemoRT for NSCLC measured by serial FLT-PET
Michael MacManus, Australia
PD-0971
a pet/ct radiomics model for predicting distant metastasis in lung cancer patients treated with SBRT
Zhen Zhang, The Netherlands
PD-0972